[
    "{\"step_by_step_thinking\": \"The patient's presentation is consistent with acute coronary syndrome (ACS), specifically an ST-segment elevation myocardial infarction (STEMI), given the characteristic chest pain, ECG changes, and elevated troponins. The initial management of STEMI involves the administration of aspirin, clopidogrel, sublingual nitroglycerin, and morphine, which have already been given to the patient. The next step in the management of this patient is reperfusion therapy to restore blood flow to the occluded coronary artery. The two main options for reperfusion therapy are percutaneous coronary intervention (PCI) and fibrinolytic therapy. PCI is the preferred option if it can be performed within 90 minutes of first medical contact. However, in this case, the patient is already admitted to a unit with continuous cardiac monitoring, suggesting that PCI may not be immediately available. Therefore, the best next step in the management of this patient is fibrinolytic therapy with intravenous alteplase (choice B). Coronary artery bypass graft (choice C) is not indicated as the initial management of STEMI. Oral ramipril (choice D) is an angiotensin-converting enzyme (ACE) inhibitor and is not the best next step in the management of this patient's acute condition.\", \"answer_choice\": \"B\"}"
]